MHRA Publishes Marketing Authorisations Granted in July 2022 MHRA’s list of marketing authorisations granted in July 2022 MHRA granted two OTC licences in July 2022. Details of these... MHRA Publishes Marketing Authorisations Granted in July 2022
MHRA Public Assessment Report – Reclassification Application to Increase Pack Size of Nicorette QuickMist 1mg/spray mouthspray & Nicorette QuickMist smart track 1mg/spray mouthspray MHRA Public Assessment Report – Reclassification Application to Increase Pack Size of Nicorette QuickMist 1mg/spray mouthspray & Nicorette QuickMist smart... MHRA Public Assessment Report – Reclassification Application to Increase Pack Size of Nicorette QuickMist 1mg/spray mouthspray & Nicorette QuickMist smart track 1mg/spray mouthspray
MHRA Nitrosamines – Step 3 Deadline Extended MHRA Nitrosamines – Medicines Marketing Authorisation Holders’ submission of Nitrosamine risk evaluation, risk assessment and confirmatory testing – Step 3... MHRA Nitrosamines – Step 3 Deadline Extended
MHRA Board Meeting – 20 September 2022 MHRA (Medicines and Healthcare products Regulatory Agency) Board Meeting – 20 September 2022 The MHRA Board will meet in public... MHRA Board Meeting – 20 September 2022
CMDh Workplan to 2025 – Published CMDh Workplan to 2025 – Published The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published its... CMDh Workplan to 2025 – Published
MHRA Public Assessment Report – Reclassification of Sudafed Plus Blocked Nose 1mg/50mg/ml Nasal Spray Solution MHRA Public Assessment Report – Reclassification of Sudafed Plus Blocked Nose 1mg/50mg/ml Nasal Spray Solution MHRA has published the Public... MHRA Public Assessment Report – Reclassification of Sudafed Plus Blocked Nose 1mg/50mg/ml Nasal Spray Solution
EU Commission – FAQ on Medicines and Medical Devices Concerning Sanctions Against Russia EU Commission – FAQ on Medicines and Medical Devices Concerning Sanctions Against Russia The Commission has published “... EU Commission – FAQ on Medicines and Medical Devices Concerning Sanctions Against Russia
CMDh July 2022 Meeting – Report CMDh July 2022 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh July 2022 Meeting – Report
HPRA – Note for Non-Pharmacy Retail Advertising of Medicines HPRA – Note for Non-Pharmacy Retail Advertising of Medicines The Health Products Regulatory Authority (HPRA) has published a note to... HPRA – Note for Non-Pharmacy Retail Advertising of Medicines
Nitrosamines – Extension of Deadline for Submitting Variation Applications for Chemical Medicines Nitrosamines – Extension of Deadline for Submitting Variation Applications for Chemical Medicines The Committee for Medicinal Products for Human Use... Nitrosamines – Extension of Deadline for Submitting Variation Applications for Chemical Medicines
New Commissioners Appointed to the Commission on Human Medicines New Commissioners Appointed to the Commission on Human Medicines Professor Tony Williams, Professor David Hunt, Professor David Dockrell, Dr Gerri... New Commissioners Appointed to the Commission on Human Medicines
Big Data – HMA-EMA Joint Big Data Taskforce Workplan Update: 2022-2025 Big Data – HMA-EMA Joint Big Data Taskforce Workplan Update: 2022-2025 The Big Data Steering Group set... Big Data – HMA-EMA Joint Big Data Taskforce Workplan Update: 2022-2025
